Mukka Proteins Hits New 52-Week Low at Rs. 24.35

Mukka Proteins has reached a significant milestone by touching its 52-week low of Rs. 24.35 on November 6, 2025. This decline marks a notable downturn for the microcap company in the FMCG sector, which has seen its stock price fall by 43.62% over the past year, contrasting sharply with the Sensex's positive performance of 3.95% during the same period. Today, Mukka Proteins underperformed its sector by 5.05%, continuing a downward trend with three consecutive days of losses, totaling a decline of 2.66%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent weakness in its market position. Financial metrics reveal challenges for Mukka Proteins, including a low Return on Capital Employed (ROCE) of 9.48% and a high Debt to EBITDA ratio of 4.36 times, suggesting difficulties in servicing debt. Additionally, the company has reported negative results for six consecutive quarters, with net sales falling by 32.1% compared to the previous quarter's average. Institutional investor participation has also declined, with a 0.6% reduction in stake over the last quarter.